激素氨酸乳酸化 (Kla) 诱导的BCAM促进OSCC进展和Cis-Platinum抵抗
Guangzhao Huang1, Su Chen1, Jialu He1
1State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Oral diseases
|November 6, 2024
概括
基 lysine乳化 (Kla) 与口腔状细胞癌 (OSCC) 的预后和瘤微环境有关. 一个Kla诱导的基因BCAM驱动OSCC的进展,可能是治疗点.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 基因组 lysine 乳糖化 (Kla) 与癌症进展有关.
- 在口腔状细胞癌 (OSCC) 中Kla的预后意义尚未明确.
研究的目的:
- 在OSCC中调查基因素Kla的预后价值.
- 探索Kla在OSCC药物敏感性和瘤微环境 (TME) 中的作用.
主要方法:
- 使用TCGA和GEO数据库用于OSCCRNA表达数据.
- 构建了一个考克斯模型来评估预后价值,并确定了与Kla相关的基因 (DEKlaGs).
- 进行GO和KEGG丰富分析以了解DEKlaG的功能.
主要成果:
- 在OSCC中鉴定了228个差异表达的Kla相关基因 (DEKlaGs),与炎症和癌症进展有关.
- 开发了一个使用BCAM,CGNL1,DGKG和OLR1的预后模型,以准确预测OSCC患者的结果.
- 发现Kla诱导的基因显著影响OSCC药物治疗和TME,BCAM促进入侵,血管生成和化学抵抗.
结论:
- 基斯Kla与OSCC预后,药物反应和TME有关.
- 由Kla诱导的BCAM是OSCC进展的关键驱动因素,强调Kla作为潜在的治疗点.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K


